Literature DB >> 15179550

Prognostic factors in renal cell carcinoma.

Börje Ljungberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15179550     DOI： 10.1007/s00120-004-0594-6

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  9 in total

1.  Serum acute phase reactants and prognosis in renal cell carcinoma.

Authors:  B Ljungberg; K Grankvist; T Rasmuson
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

2.  Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases.

Authors:  D G Skinner; R B Colvin; C D Vermillion; R C Pfister; W F Leadbetter
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

3.  Prognostic significance of the Heidelberg classification of renal cell carcinoma.

Authors:  B Ljungberg; F I Alamdari; R Stenling; G Roos
Journal:  Eur Urol       Date:  1999-12       Impact factor: 20.096

Review 4.  The Heidelberg classification of renal cell tumours.

Authors:  G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar
Journal:  J Pathol       Date:  1997-10       Impact factor: 7.996

5.  Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.

Authors:  J Jacobsen; T Rasmuson; K Grankvist; B Ljungberg
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  Tumor-cell proliferation and prognosis in renal-cell carcinoma.

Authors:  P Larsson; G Roos; R Stenling; B Ljungberg
Journal:  Int J Cancer       Date:  1993-10-21       Impact factor: 7.396

7.  An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

Authors:  Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

8.  Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases.

Authors:  Vincenzo Ficarra; Rita Righetti; Stefania Pilloni; Antonio D'amico; Nicola Maffei; Giovanni Novella; Luisa Zanolla; Gianni Malossini; Gaetano Mobilio
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

9.  Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.

Authors:  Y Hedberg; B Ljungberg; G Roos; G Landberg
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640
  9 in total
  9 in total

Review 1.  Immunotherapy in metastatic renal cell carcinoma.

Authors:  Karl Rohrmann; Michael Staehler; Nikolas Haseke; Alexander Bachmann; Christian G Stief; Michael Siebels
Journal:  World J Urol       Date:  2005-04-02       Impact factor: 4.226

2.  Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.

Authors:  Joana Heinzelmann; Brenda Henning; Jimsgene Sanjmyatav; Nicole Posorski; Thomas Steiner; Heiko Wunderlich; Mieczyslaw R Gajda; Kerstin Junker
Journal:  World J Urol       Date:  2011-01-13       Impact factor: 4.226

3.  Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).

Authors:  M Abbas; S Steffens; M Bellut; H Eggers; A Großhennig; J U Becker; G Wegener; A J Schrader; V Grünwald; P Ivanyi
Journal:  Med Oncol       Date:  2016-06-17       Impact factor: 3.064

4.  Metastasis-Initiating Cells in Renal Cancer.

Authors:  Mohammed I Khan; Anna M Czarnecka; Renata Duchnowska; Wojciech Kukwa; Cezary Szczylik
Journal:  Curr Signal Transduct Ther       Date:  2014-12

5.  HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma.

Authors:  Carla Micucci; Giulia Matacchione; Debora Valli; Silvia Orciari; Alfonso Catalano
Journal:  Br J Cancer       Date:  2015-10-06       Impact factor: 7.640

6.  A Novel mRNA-miRNA Regulatory Sub-Network Associated With Prognosis of Metastatic Clear Cell Renal Cell Carcinoma.

Authors:  Tianyu Yang; Xiaofen Miao; Zhanxiang Bai; Jian Tu; Shanshan Shen; Hui Niu; Wei Xia; Juan Wang; Yongsheng Zhang
Journal:  Front Oncol       Date:  2021-01-19       Impact factor: 6.244

7.  MRI-Based Grading of Clear Cell Renal Cell Carcinoma Using a Machine Learning Classifier.

Authors:  Xin-Yuan Chen; Yu Zhang; Yu-Xing Chen; Zi-Qiang Huang; Xiao-Yue Xia; Yi-Xin Yan; Mo-Ping Xu; Wen Chen; Xian-Long Wang; Qun-Lin Chen
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

8.  Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.

Authors:  Sandra Steffens; Astrid Köhler; Raphael Rudolph; Hendrik Eggers; Christoph Seidel; Martin Janssen; Gerd Wegener; Mark Schrader; Markus A Kuczyk; Andres J Schrader
Journal:  BMC Cancer       Date:  2012-09-08       Impact factor: 4.430

9.  GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.

Authors:  Inga Peters; Kai Gebauer; Natalia Dubrowinskaja; Faranaz Atschekzei; Mario W Kramer; Joerg Hennenlotter; Hossein Tezval; Mahmoud Abbas; Ralph Scherer; Axel S Merseburger; Arnulf Stenzl; Markus A Kuczyk; Juergen Serth
Journal:  Oncol Rep       Date:  2014-02-18       Impact factor: 3.906
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.